论文信息 - Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma. - 字舞流文

Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma.

R. Fonseca | S. Dakhil | S. Kaufmann | I. Ghobrial | S. Ansell | S. Geyer | T. Witzig | P. Flynn | R. Morton | D. Inwards | H. Gross | Paul J. Kurtin | R. Luyun